Physician profile
Bruce C Depew
NPI 1376505214
$2,475.73
in general payments reported to CMS, 2019-2025
38 companies · $640 in 2025
The $640 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $548 · 2020: $103 · 2021: $152 · 2022: $12.81 · 2023: $470 · 2024: $550 · 2025: $640.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,660.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $277.52 | 2019-2025 | Veozah |
| Novo Nordisk INC | $154.57 | 2019-2025 | Ozempic, Rybelsus |
| Amgen INC. | $151.40 | 2019-2025 | Otezla, Repatha, Repatha |
| Ironshore Pharmaceuticals INC. | $149.32 | 2023-2024 | Jornay Pm |
| Janssen Pharmaceuticals, INC | $133.96 | 2019-2024 | Xarelto |
| Glaxosmithkline, LLC. | $128.17 | 2019-2025 | Arexvy, Shingrix, Bexsero |
| Astrazeneca Pharmaceuticals LP | $124.56 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $123.22 | 2019-2025 | |
| Abbvie INC. | $103.47 | 2021-2024 | |
| Abbott Laboratories | $101.21 | 2021-2025 | Freestyle Libre 3 |
| Cranial Technologies, INC | $90.59 | 2019-2025 | Doc Band |
| Pfizer INC. | $87.50 | 2019-2025 | |
| Supernus Pharmaceuticals, INC. | $86.00 | 2023-2025 | Qelbree, Qelbree |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $83.78 | 2025 | Caplyta |
| Merck Sharp & Dohme LLC | $69.43 | 2019-2025 | M-M-R II, Capvaxive, Vaxelis |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Depew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.